Clinical Trials Update: Jan. 30, 2004

Depression Osteoarthritis Mantle Cell Lymphoma

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Depression

A clinical research study of an investigational medication for the treatment of depression. Volunteers between ages 18 and 64 who have been experiencing symptoms including hopelessness, sadness, loss of interest in daily activities, and difficulty concentrating may be eligible. Research site located in Lakewood, Wash.

More Information

Please see http://www.centerwatch.com/patient/studies/cat164.html.

-----

Osteoarthritis

A research study of an investigational medication for the treatment of osteoarthritis. Volunteers at least 40 years old who have tried taking prescription strengths of ibuprofen and naproxen (Aleve) for osteoarthritis, but have not found relief, may be eligible. Research site located in Eugene, Ore.

More Information

Please see http://www.centerwatch.com/patient/studies/cat109.html.

-----

Mantle Cell Lymphoma

A research study of an investigational medication for treatment of mantle cell lymphoma. The study drug has been approved by the U.S. Food and Drug Administration to treat other conditions, but not yet to treat mantle cell lymphoma. Volunteers 18 and older who have been diagnosed with mantle cell lymphoma may be eligible. Research site located in Iowa City, Iowa.

More Information

Please see http://www.centerwatch.com/patient/studies/cat628.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com